Neurologists and the threat of bioterrorism

Journal of the Neurological Sciences

Volumn 249, Issue 1, 2006, Pages 55-62

  Donaghy, Michael ^a,b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b OXFORD UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Anthrax; Bioweapons; Botulism; Equine encephalitis; Saxitoxin; Tetrodotoxin

Indexed keywords

BOTULINUM TOXIN; CHEMICAL WARFARE AGENT; NEUROTOXIN; ORGANOPHOSPHATE; SAXITOXIN; SNAKE VENOM; TETRODOTOXIN;

ANTHRAX; ARTICLE; AUTONOMIC NERVOUS SYSTEM; BIOLOGICAL WARFARE; BRAIN INFECTION; BULBAR PARALYSIS; CLINICAL FEATURE; DEATH; DIAGNOSTIC PROCEDURE; DIFFERENTIAL DIAGNOSIS; DIPHTHERIA; ENCEPHALITIS; ENVENOMATION; EXTRAOCULAR MUSCLE; GUILLAIN BARRE SYNDROME; HUMAN; INGESTION; INHALATION; INTOXICATION; MEDICAL SPECIALIST; MUSCLE FUNCTION; MYASTHENIA; NERVE STIMULATION; NEUROLOGY; NEUROPSYCHOLOGY; PANIC; PARALYSIS; PRIORITY JOURNAL; SEA FOOD; SYMPTOMATOLOGY; VIRUS INFECTION;

ANIMALS; ANTHRAX; BIOTERRORISM; BOTULINUM TOXINS; BOTULISM; CIVIL DISORDERS; DIAGNOSIS, DIFFERENTIAL; ENCEPHALOMYELITIS, VENEZUELAN EQUINE; HUMANS; MASS BEHAVIOR; MASS SCREENING; NEUROLOGY;

EID: 33750524212     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2006.06.004     Document Type: Article

References (51)

1. NATO. NATO handbook on the medical aspects of NBC defensive operations. AMedP-6(C) 2003; Part II - Biological.
2. Arnon S.S., Schechter R., Inglesby T.V., Henderson D.A., Barlett J.G., Ascher M.S., et al. Botulinum toxin as a biological weapon: medical and public health management. JAMA 285 (2001) 1059-1070
3. Jernigan J.A., Stephens D.S., Ashford D.A., Omenaca C., Topiel M.S., Galbraith M., et al. Bioterrorism-related inhalational anthrax: the first 10 cases reported in the United States. Emerg Infect Dis 7 (2001) 933-944
4. Jackson P.J., Hugh-Jones M.E., Adair D.M., Green G., Hill K.K., Kuske C.R., et al. PCR analysis of tissue samples from the 1979 Sverdlovsk anthrax victims: the presence of multiple Bacillus anthracis strains in different victims. Proc Natl Acad Sci U S A 95 (1998) 1224-1229
5. Manchee R.J., Broster M.G., Melling J., Henstridge R.M., and Stagg A.J. Bacillus anthracis on Gruinard Island. Nature 294 (1981) 254-255
6. Klotzko A.J. Science matters (2004 (August 14)), Financial Times Magazine 13
7. Gill M. Bacterial toxins: a table of lethal amounts. Microbiol Rev 46 (1982) 86-94
8. Schantz E.J., and Johnson E.A. Properties and use of botulinum toxin and other microbial neurotoxins in medicine. Microbiol Rev 56 (1992) 80-99
9. Herrero B.A., Ecklung A.E., Streett C.S., Ford D.F., and King J.K. Experimental botulism in monkeys - a clinical pathological study. Exp Mol Pathol 6 (1967) 84-95
10. Scott A.B., and Suzuki D. Systemic toxicity of botulinum toxin by intramuscular injection in the monkey. Mov Disord 3 (1988) 333-335
11. Lacy D.B., Tepp W., Cohen A.C., DasGupta B.R., and Stevens R.C. Crystal structure of botulinum neurotoxin type A and implications for toxicity. Nat Struct Biol 5 (1998) 898-902
12. Shapiro R.L., Hatheway C., and Swerdlow D.L. Botulism in the United States: a clinical and epidemiologic review. Ann Intern Med 129 (1998) 221-228
13. Weber J.T., Goodpasture H.C., Alexander H., Werner S.B., Hatheway C.L., and Tauxe R.V. Wound botulism in a patient with a tooth abscess: case report and review. Clin Infect Dis 16 (1993) 635-639
14. Merson M.H., and Dowell Jr. V.R. Epidemiologic, clinical and laboratory aspects of wound botulism. N Engl J Med 289 (1973) 1005-1010
15. Chia J.K., Clark J.B., Ryan C.A., and Pollack M. Botulism in an adult associated with food-borne intestinal infection with Clostridium botulinum. N Engl J Med 315 (1986) 239-241
16. Holzer V. Botulism from inhalation. Med Klin 57 (1962) 1735-1738 [in German]
17. Franz D., Pitt L., Clayton M., Hanes M.A., and Rose K.J. Efficacy of prophylactic and therapeutic administration of antitoxin for inhalation botulism. In: DasGupta B.R. (Ed). Botulinum and tetanus neurotoxins: neurotransmission and biomedical aspects (1993), Plenum Press, New York 473-476
18. Burrows W.D., and Renner S.E. Biological warfare agents as threats to potable water. Environ Health Perspect 107 (1999) 975-984
19. Terranova W., Breman J.G., Locey R.P., and Speck S. Botulism type B: epidemiologic aspects of an extensive outbreak. Am J Epidemiol 108 (1978) 150-156
20. Zilinskas R.A. Iraq's biological weapons. The past as future?. JAMA 278 (1997) 418-424
21. Alibek K., and Handleman S. Biohazard (1999), Random House, New York
22. Hughes J.M., Blumenthal J.R., Merson M.H., Lombard G.L., Dowell Jr. V.R., and Gangarosa E.J. Clinical features of types A and B food-borne botulism. Ann Intern Med 95 (1981) 442-445
23. CDCP. Botulism in the United States, 1899-1973 (1978), Centers for Disease Control, Atlanta
24. Duchen L.W. An electron microscopic study of the changes induced by botulinum toxin in the motor end-plates of slow and fast skeletal muscle fibres of the mouse. J Neurol Sci 14 (1971) 47-60
25. Donaghy M., and Duchen L.W. Sera from patients with motor neuron disease and associated paraproteinaemia fail to inhibit experimentally induced sprouting of motor nerve terminals. J Neurol Neurosurg Psychiatry 49 (1986) 817-819
26. Tsujihata M., Kinoshita I., Mori M., Mori K., Shirabe S., Satoh A., et al. Ultrastructural study of the motor end-plate in botulism and Lambert-Eaton myasthenic syndrome. J Neurol Sci 81 (1987) 197-213
27. Burnett J.C., Henchal E.A., Schmaljohn A.L., and Bavari S. The evolving field of biodefence: therapeutic developments and diagnostics. Nat Rev Drug Discov 4 (2005) 281-297
28. Hibbs R.G., Weber J.T., Corwin A., Allos B.M., Abd el Rehim M.S., Sharkawy S.E., et al. Experience with the use of an investigational F(ab′)2 heptavalent botulism immune globulin of equine origin during an outbreak of type E botulism in Egypt. Clin Infect Dis 23 (1996) 337-340
29. Tacket C.O., Shandera W.X., Mann J.M., Hargrett N.T., and Blake P.A. Equine antitoxin use and other factors that predict outcome in type A foodborne botulism. Am J Med 76 (1984) 794-798
30. Dorsey E., Beebe J., and Johns E. Responses of airborne Clostridium botulinum toxin to certain atmospheric stresses. Technical Memorandum vol. 62 (1964), US Army Biological Laboratories, Frederick (MD)
31. Brachman P.S. Inhalation anthrax. Ann N Y Acad Sci 353 (1980) 83-93
32. CDCP. Summary of notifiable diseases 1945-1994. MMWR Morb Mortal Wkly Rep 43 (1994) 70-78
33. Inglesby T.V., Henderson D.A., Bartlett J.G., Ascher M.S., Eitzen E., Friedlander A.M., et al. Anthrax as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. JAMA 281 (1999) 1735-1745
34. Meselson M., Guillemin J., Hugh-Jones M., Langmuir A., Popova I., Shelokov A., et al. The Sverdlovsk anthrax outbreak of 1979. Science 266 (1994) 1202-1208
35. Rangel R.A., and Gonzalez D.A. Bacillus anthracis meningitis. Neurology 25 (1975) 525-530
36. Pluot M., Vital C., Aubertin J., Croix J.C., Pire J.C., and Poisot D. Anthrax meningitis. Report of two cases with autopsies. Acta Neuropathol 36 (1976) 339-345
37. Dixon T.C., Meselson M., Guillemin J., and Hanna P.C. Anthrax. N Engl J Med 341 (1999) 815-826
38. Berthier M., Fauchere J.L., Perrin J., Grignon B., and Oriot D. Fulminant meningitis due to Bacillus anthracis in 11-year-old girl during Ramadan. Lancet 347 (1996) 828
39. Abramova F.A., Grinberg L.M., Yampolskaya O.V., and Walker D.H. Pathology of inhalational anthrax in 42 cases from the Sverdlovsk outbreak of 1979. Proc Natl Acad Sci U S A 90 (1993) 2291-2294
40. Martin C.O., and Adams Jr. H.P. Neurological aspects of biological and chemical terrorism: a review for neurologists. Arch Neurol 60 (2003) 21-25
41. Tahernia A.C., and Hashemi G. Survival in anthrax meningitis. Pediatrics 50 (1972) 329-333
42. Friedlander A.M., Pittman P.R., and Parker G.W. Anthrax vaccine: evidence for safety and efficacy against inhalational anthrax. JAMA 282 (1999) 2104-2106
43. Lehane L. Paralytic shellfish poisoning: a potential public health problem. Med J Aust 175 (2001) 29-31
44. Kiernan M.C., Isbister G.K., Lin C.S., Burke D., and Bostock H. Acute tetrodotoxin-induced neurotoxicity after ingestion of puffer fish. Ann Neurol 57 (2005) 339-348
45. de Carvalho M., Jacinto J., Ramos N., de Oliveiro V., Pinho e Melo T., and de Sa J. Paralytic shellfish poisoning: clinical and electrophysiological observations. J Neurol 245 (1998) 551-554
46. Garcia C., del Carmen Bravo M., Lagos M., and Lagos N. Paralytic shellfish poisoning: post-mortem analysis of tissue and body fluid samples from human victims in the Patagonia fjords. Toxicon 43 (2004) 149-158
47. Isbister G.K., Son J., Wang F., Maclean C.J., Lin C.S., Ujma J., et al. Puffer fish poisoning: a potentially life-threatening condition. Med J Aust 177 (2002) 650-653
48. Petersen L., and Gubler D. Alphaviruses. In: Warrell D., Cox T., Firth J., and Benz E. (Eds). Oxford textbook of medicine. 4th ed. (2003), Oxford University Press, Oxford 377-380
49. Dumpis U., Crook D., and Oksi J. Tick-borne encephalitis. Clin Infect Dis 28 (1999) 882-890
50. Logina I., and Donaghy M. Diphtheritic polyneuropathy: a clinical study and comparison with Guillain-Barré syndrome. J Neurol Neurosurg Psychiatry 67 (1999) 433-438
51. Ropper A., Wijdicks E., and Truax B. Guillain-Barré syndrome (1991), FA Davis Co, Philadelphia